Blog Archive
-
▼
2010
(63)
-
▼
May
(9)
- Breathe Technologies Secures $23 Million in Series...
- Funxional Therapeutics : ...10 million Euros... to...
- Cardiocom : Telehealth Platform with New Pulse Oxi...
- Cytokinetics : Non-Clinical Data from Its Smooth M...
- Galapagos and Roche : COPD alliance
- Cellceutix : Important New Data on Kevetrin(TM) i...
- Nabriva Therapeutics : successful Phase I clinical...
- NexBio : Clinical Trial of DAS181 (Fludase®*) in A...
- Mylan Pharmaceuticals : Approval for Generic Versi...
-
▼
May
(9)
May 25, 2010
Cytokinetics : Non-Clinical Data from Its Smooth Muscle Contractility Program at the American Thoracic Society’s 2010 International Conference
May 18, 2010 - Inhibitors of Smooth Muscle Myosin May Offer a Novel Therapeutic Approach to the Treatment of Chronic Obstructive Pulmonary Disease and Asthma - Cytokinetics, Incorporated (Nasdaq: CYTK) announced that a poster summarizing non-clinical data regarding its smooth muscle contractility program was presented at the American Thoracic Society’s 2010 International Conference which was held May 14-19, 2010 at the Ernest N. Morial Convention Center in New Orleans, LA... Cytokinetics' Press Release -